| Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects F Holze, L Ley, F Müller, AM Becker, I Straumann, P Vizeli, SS Kuehne, ... Neuropsychopharmacology 47 (6), 1180-1187, 2022 | 100 | 2022 |
| Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double‐blind, placebo‐controlled, crossover study in healthy subjects AM Becker, F Holze, T Grandinetti, A Klaiber, VE Toedtli, KE Kolaczynska, ... Clinical Pharmacology & Therapeutics 111 (4), 886-895, 2022 | 86 | 2022 |
| Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants F Müller, E Kraus, F Holze, A Becker, L Ley, Y Schmid, P Vizeli, ME Liechti, ... Psychopharmacology 239 (6), 1933-1943, 2022 | 37 | 2022 |
| Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants AM Becker, A Klaiber, F Holze, I Istampoulouoglou, U Duthaler, ... International Journal of Neuropsychopharmacology 26 (2), 97-106, 2023 | 36 | 2023 |
| Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants L Ley, F Holze, D Arikci, AM Becker, I Straumann, A Klaiber, F Coviello, ... Neuropsychopharmacology 48 (11), 1659-1667, 2023 | 31 | 2023 |
| Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants SB Vogt, L Ley, L Erne, I Straumann, AM Becker, A Klaiber, F Holze, ... Translational Psychiatry 13 (1), 172, 2023 | 29 | 2023 |
| Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants F Holze, AM Becker, KE Kolaczynska, U Duthaler, ME Liechti Clinical Pharmacology & Therapeutics 113 (4), 822-831, 2023 | 23 | 2023 |
| Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants I Straumann, L Ley, F Holze, AM Becker, A Klaiber, K Wey, U Duthaler, ... Neuropsychopharmacology 48 (13), 1840-1848, 2023 | 9 | 2023 |
| The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies K Stocker, M Hartmann, L Ley, AM Becker, F Holze, ME Liechti Journal of psychopharmacology 38 (1), 80-100, 2024 | 2 | 2024 |
| Antidepressant-psilocybin co-treatment to assist psychotherapy ME Liechti, AM Becker US Patent 11,801,256, 2023 | | 2023 |
